Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.
Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease. Lung. 2025 Jan 22; 203(1):27.
PMID: 39841267
Impact of Letermovir for Cytomegalovirus Primary Prophylaxis on Myelosuppression and Immunosuppression in Lung Transplant Recipients.
Impact of Letermovir for Cytomegalovirus Primary Prophylaxis on Myelosuppression and Immunosuppression in Lung Transplant Recipients. Clin Transplant. 2024 Dec; 38(12):e70033.
PMID: 39601243
Right Heart Recovery Post Lung Transplant With COVID-19-Related Acute Respiratory Distress Syndrome.
Right Heart Recovery Post Lung Transplant With COVID-19-Related Acute Respiratory Distress Syndrome. J Transplant. 2024; 2024:8483800.
PMID: 39583316
Suction Thrombectomy and Pulmonary Artery Stenting for Pulmonary Embolism in a Single Lung Transplant.
Suction Thrombectomy and Pulmonary Artery Stenting for Pulmonary Embolism in a Single Lung Transplant. Am J Respir Crit Care Med. 2024 Nov 01; 210(9):e12-e13.
PMID: 38843509
Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer.
Multiorgan transplant for therapy-associated lung and liver failure in a patient with stage III lung cancer. Am J Transplant. 2025 Jan; 25(1):209-214.
PMID: 39278626
Respiratory-swallow patterning and oropharyngeal swallowing impairment in patients undergoing evaluation for lung transplant.
Respiratory-swallow patterning and oropharyngeal swallowing impairment in patients undergoing evaluation for lung transplant. Neurogastroenterol Motil. 2024 Nov; 36(11):e14912.
PMID: 39223932
Impact of bridging veno-venous extracorporeal membrane oxygenation to COVID-19 lung transplantation.
Impact of bridging veno-venous extracorporeal membrane oxygenation to COVID-19 lung transplantation. J Thorac Dis. 2024 Jul 30; 16(7):4417-4428.
PMID: 39144296
Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients.
Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients. Transpl Infect Dis. 2024 Oct; 26(5):e14337.
PMID: 38980979
Predictors of Cytomegalovirus Recurrence Following Cessation of Posttransplant Prophylaxis.
Predictors of Cytomegalovirus Recurrence Following Cessation of Posttransplant Prophylaxis. J Surg Res. 2024 Jul; 299:129-136.
PMID: 38754251
Infectious Complications of Lung Transplant for Coronavirus Disease 2019-Associated Lung Injury: A Single-Center Case-Control Cohort Study.
Infectious Complications of Lung Transplant for Coronavirus Disease 2019-Associated Lung Injury: A Single-Center Case-Control Cohort Study. Clin Infect Dis. 2023 07 26; 77(2):220-228.
PMID: 36942560